Sign In
Buy OPRX
$6.05
-0.220 (-3.51%)
At Close: Jul 31, 2026
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
07:30am, Monday, 11'th May 2026
Expands life sciences marketers' reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx's trusted EHR network for the first time Expands life sciences marketers' rea
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
11:30am, Thursday, 07'th May 2026
OptimizeRx nears Q1 earnings amid declining revenue forecasts, softer trends and a cautious outlook, raising questions on near-term upside.
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline
11:00am, Tuesday, 05'th May 2026
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing OptimizeRx (OPRX) Right Now?
10:40am, Monday, 04'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
04:05pm, Wednesday, 29'th Apr 2026
WALTHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
08:00am, Tuesday, 28'th Apr 2026
WALTHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage heal
Cadence Design Systems (CDNS) Q1 Earnings and Revenues Top Estimates
06:31pm, Monday, 27'th Apr 2026
Cadence Design Systems (CDNS) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.57 per share a year ago.
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?
09:21am, Friday, 24'th Apr 2026
OPRX edges past GDRX with AI-driven platform momentum, stronger estimates and lower valuation despite near-term revenue headwinds.
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine?
10:06am, Thursday, 23'rd Apr 2026
OptimizeRx rides AI-driven engagement gains, as oncology pilots scale to multi-brand deals and med tech traction fuels rising enterprise investment momentum.
Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds?
11:11am, Tuesday, 21'st Apr 2026
OPRX's rising cash flow, DAAP adoption and expanding pharma ties boost outlook despite near-term revenue softness and cautious client spending.
OPRX Trades at a Discount to Industry: How to Approach the Stock Now?
12:16pm, Friday, 17'th Apr 2026
OptimizeRx trades at a steep discount to peers, but strong AI-driven growth, rising cash flow and DAAP traction look encouraging.
Should Value Investors Buy OptimizeRx (OPRX) Stock?
10:41am, Friday, 17'th Apr 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern?
09:56am, Tuesday, 14'th Apr 2026
OptimizeRx lowers 2026 revenue forecast on shifting pharma spend and managed services drag, but signals recovery ahead and stronger EBITDA expectations.
OptimizeRx Appoints Mary Varghese Presti to Board of Directors
04:05pm, Wednesday, 08'th Apr 2026
Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiency Microsoft Health & Life Sciences COO brings
OptimizeRx (NASDAQ:OPRX) vs. Synopsys (NASDAQ:SNPS) Head-To-Head Analysis
02:02am, Monday, 06'th Apr 2026
Synopsys (NASDAQ: SNPS - Get Free Report) and OptimizeRx (NASDAQ: OPRX - Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies
